News

Cipla Medpro subsidiary Medpro Pharmaceutica has entered into an agreement with Teva Pharmaceuticals. As part of the deal, Medpro will exclusively market Teva's pharmaceutical product portfolio in South Africa. Cipla Medpro CEO Paul Miller said:...

Austria-based Nabriva Therapeutics has received qualified infectious disease product (QIDP) and fast-track status designation from the US Food and Drug Administration for its lefamulin (BC 3781). The designation has been granted for lefamulin...

US-based Pfizer has introduced a new scratch card in a bid to involve the public in medicines optimisation. The card has been designed to increase patient engagement with the pharmacy team and create opportunities to...

US-based Johnson & Johnson has signed an agreement to acquire a privately held clinical stage biopharmaceutical company, Alios BioPharma, for $1.75bn in cash. Based in California, US, Alios develops therapies for the treatment of...

The courier firm FedEx faces drug-trafficking charges after being indicted by a federal grand jury in California, in a case that highlights the growth in illegal online pharmacies selling dubious medication to people without prescription. The...

AIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said the number of new HIV infections and deaths from Aids were both falling. At present,...

AbbVie has now laid on the table a bid of £53.20 a share to acquire UK-headquartered Shire, up from last week’s offer of £51.15. Shire confirmed this morning that following talks it requested, and received, a...